European Markets for Orthopedic Biomaterials 2009

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

• 1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIAL MARKET
• 1.2 AUTOGRAFTED BONE PROCEDURES
• 1.3 BONE GRAFT SUBSTITUTE WASTAGE
• 1.4 ALLOGRAFT, DBM AND SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
• 1.5 HYALURONIC VISCOSUPPLEMENT MARKET
• 1.6 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
• 1.7 BMP GROWTH FACTOR MARKET
• 1.8 PLATELET AND BONE MARROW CONCENTRATION MARKET
• 1.9 LEADING COMPETITORS

RESEARCH METHODOLOGY

• 2.1 RESEARCH SCOPE
• 2.2 IDATA' S 9-STEP METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Survey Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecasting
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS

• 3.1 INTRODUCTION
• 3.2 OVERVIEW
  • 3.2.1 Growth Factors
  • 3.2.2 Bone Graft Substitutes
  • 3.2.3 Hyaluronic Acid Viscosupplementation
  • 3.2.4 Autologous Chondrocyte Implantation (ACI)
  • 3.2.5 Platelet and Bone Marrow Concentration
• 3.3 CURRENCY EXCHANGE RATE
• 3.4 MARKET ANALYSIS AND FORECAST
  • 3.4.1 Analysis and Forecast of Total Market
• 3.5 MARKET DRIVERS
• 3.6 MARKET LIMITERS
• 3.7 COMPETITIVE ANALYSIS
  • 3.7.1 Leading Competitors
  • 3.7.2 Market Concentration
• 3.8 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

• 4.1 INTRODUCTION
  • 4.1.1 Population
  • 4.1.2 GDP per Capita
  • 4.1.3 Procedures
  • 4.1.4 Price Index
  • 4.1.5 Germany
• 4.2 FRANCE
• 4.3 UNITED KINGDOM
• 4.4 SPAIN
• 4.5 ITALY
• 4.6 BENELUX
• 4.7 SCANDINAVIA
• 4.8 SWITZERLAND
• 4.9 AUSTRIA
• 4.10 PORTUGAL
• 4.11 GREECE

BONE GRAFT SUBSTITUTE MARKET

• 5.1 TOTAL MARKET
  • 5.1.1 Introduction
  • 5.1.2 Overview
  • 5.1.3 Volume Usage and Pricing
    • 5.1.3.1 Wastage
    • 5.1.3.2 Volumes Represented per Procedure
  • 5.1.4 Autograft Procedures
  • 5.1.5 Spine Fusion Procedures
  • 5.1.6 Market Analysis and Forecast
    • 5.1.6.1 Total Commercial Bone Graft Substitute Market
    • 5.1.6.2 Total Utilized Bone Graft Substitute Market
    • 5.1.6.3 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.1.6.4 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.1.6.5 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.1.6.6 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.1.6.7 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.1.7 Market Drivers and Limiters
    • 5.1.7.1 Market Drivers
    • 5.1.7.2 Market Limiters
  • 5.1.8 Competitive Analysis
    • 5.1.8.1 Bone Graft Substitute Market
    • 5.1.8.2 Spinal Fusion Market Leading Competitors
• 5.2 GERMANY
  • 5.2.1 Autograft Procedures
  • 5.2.2 Spine Fusion Procedures
  • 5.2.3 Market Forecast and Analysis
    • 5.2.3.1 Total Commercial Bone Graft Substitute Market
    • 5.2.3.2 Total Utilized Bone Graft Substitute Market
    • 5.2.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.2.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.2.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.2.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.2.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.2.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.2.4 Market Drivers and Limiters
    • 5.2.4.1 Market Drivers
    • 5.2.4.2 Market Limiters
  • 5.2.5 France
  • 5.2.6 Autograft Procedures
  • 5.2.7 Spine Fusion Procedures
  • 5.2.8 Market Forecast and Analysis
    • 5.2.8.1 Total Commercial Bone Graft Substitute Market
    • 5.2.8.2 Total Utilized Bone Graft Substitute Market
    • 5.2.8.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.2.8.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.2.8.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.2.8.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.2.8.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.2.8.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.2.9 Market Drivers and Limiters
  • 5.2.9.1 Market Drivers
  • 5.2.9.2 Market Limiters
• 5.3 UNITED KINGDOM
  • 5.3.1 Autograft Procedures
  • 5.3.2 Spine Fusion Procedures
  • 5.3.3 Market Forecast and Analysis
    • 5.3.3.1 Total Commercial Bone Graft Substitute Market
    • 5.3.3.2 Total Utilized Bone Graft Substitute Market
    • 5.3.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.3.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.3.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.3.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.3.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.3.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.3.4 Market Drivers and Limiters
    • 5.3.4.1 Market Drivers
    • 5.3.4.2 Market Limiters
• 5.4 SPAIN
  • 5.4.1 Autograft Procedures
  • 5.4.2 Spine Fusion Procedures
  • 5.4.3 Market Forecast and Analysis
    • 5.4.3.1 Total Commercial Bone Graft Substitute Market
    • 5.4.3.2 Total Utilized Bone Graft Substitute Market
    • 5.4.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.4.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.4.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.4.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.4.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.4.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.4.4 Market Drivers and Limiters
    • 5.4.4.1 Market Drivers
    • 5.4.4.2 Market Limiters
• 5.5 ITALY
  • 5.5.1 Autograft Procedures
  • 5.5.2 Spine Fusion Procedures
  • 5.5.3 Market Forecast and Analysis
    • 5.5.3.1 Total Commercial Bone Graft Substitute Market
    • 5.5.3.2 Total Utilized Bone Graft Substitute Market
    • 5.5.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.5.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.5.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.5.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.5.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.5.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.5.4 Market Drivers and Limiters
    • 5.5.4.1 Market Drivers
    • 5.5.4.2 Market Limiters
• 5.6 BENELUX
  • 5.6.1 Autograft Procedures
  • 5.6.2 Spine Fusion Procedures
  • 5.6.3 Market Forecast and Analysis
    • 5.6.3.1 Total Commercial Bone Graft Substitute Market
    • 5.6.3.2 Total Utilized Bone Graft Substitute Market
    • 5.6.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.6.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.6.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.6.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.6.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.6.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.6.4 Market Drivers and Limiters
    • 5.6.4.1 Market Drivers
    • 5.6.4.2 Market Limiters
• 5.7 SCANDINAVIA
  • 5.7.1 Autograft Procedures
  • 5.7.2 Spine Fusion Procedures
  • 5.7.3 Market Forecast and Analysis
    • 5.7.3.1 Total Commercial Bone Graft Substitute Market
    • 5.7.3.2 Total Utilized Bone Graft Substitute Market
    • 5.7.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.7.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.7.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.7.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.7.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.7.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.7.4 Market Drivers and Limiters
  • 5.7.4.1 Market Drivers
  • 5.7.4.2 Market Limiters
• 5.8 SWITZERLAND
  • 5.8.1 Autograft Procedures
  • 5.8.2 Spine Fusion Procedures
  • 5.8.3 Market Forecast and Analysis
    • 5.8.3.1 Total Commercial Bone Graft Substitute Market
    • 5.8.3.2 Total Utilized Bone Graft Substitute Market
    • 5.8.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.8.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
  • 5.10.4 Market Drivers and Limiters
    • 5.10.4.1 Market Drivers
    • 5.10.4.2 Market Limiters
• 5.11 GREECE
  • 5.11.1 Autograft Procedures
  • 5.11.2 Spine Fusion Procedures
  • 5.11.3 Market Forecast and Analysis
    • 5.11.3.1 Total Commercial Bone Graft Substitute Market
    • 5.11.3.2 Total Utilized Bone Graft Substitute Market
    • 5.11.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.11.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.11.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
    • 5.11.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
    • 5.11.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
    • 5.11.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
  • 5.11.4 Market Drivers and Limiters
    • 5.11.4.1 Market Drivers
    • 5.11.4.2 Market Limiters

BMP GROWTH FACTOR MARKET

• 6.1 INTRODUCTION
  • 6.1.1 Overview
  • 6.1.2 Potential Complications
  • 6.1.3 Future Indications
• 6.2 MARKET ANALYSIS AND FORECAST
• 6.3 MARKET DRIVERS AND LIMITERS
  • 6.3.1.1 Market Drivers
  • 6.3.1.2 Market Limiters
• 6.4 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• 7.1 INTRODUCTION
  • 7.1.1 Three-Injection Cycle Products
  • 7.1.2 Five-Injection Cycle Products
  • 7.1.3 Single-Injection Cycle Products
• 7.2 MARKET ANALYSIS AND FORECAST
  • 7.2.1 Total Market
  • 7.2.2 Single-Cycle
  • 7.2.3 Three-Cycle
  • 7.2.4 Five-Cycle
  • 7.2.5 Hyaluronic Acid Viscosupplementation Injections per Country
• 7.3 MARKET DRIVERS AND LIMITERS
  • 7.3.1 Market Drivers
  • 7.3.2 Market Limiters
• 7.4 COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• 8.1 INTRODUCTION
• 8.2 OVERVIEW
• 8.3 MARKET FORECAST AND ANALYSIS
• 8.4 MARKET DRIVERS AND LIMITERS
  • 8.4.1.1 Market Drivers
  • 8.4.1.2 Market Limiters
• 8.5 COMPETITIVE ANALYSIS

PLATELET AND BONE MARROW CONCENTRATION MARKET

• 9.1 INTRODUCTION
• 9.2 OVERVIEW
  • 9.2.1 Platelet Rich Plasma
  • 9.2.2 Bone Marrow Aspirate
• 9.3 MARKET ANALYSIS AND FORECAST
  • 9.3.1.1 Total Cell Concentration Market
  • 9.3.1.2 Platelet Concentration
  • 9.3.1.3 Bone Marrow Concentration
• 9.4 MARKET DRIVERS AND LIMITERS
  • 9.4.1.1 Market Drivers
  • 9.4.1.2 Market Limiters
• 9.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES

LIST OF FIGURES

EXECUTIVE SUMMARY 1

RESEARCH METHODOLOGY 9

OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS 20

• Figure 3-1: Exchange Rate Between Euro and Other Currencies, 2008 23
• Figure 3-2: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (€) 25
• Figure 3-3: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (US$) 25
• Figure 3-4: Market Drivers, Orthopedic Biomaterials Market, Europe, 2008 27
• Figure 3-5: Market Limiters, Orthopedic Biomaterials Market, Europe, 2008 28
• Figure 3-6: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2008 30
• Figure 3-7: Other Notable Competitors, Orthopedic Biomaterial Market, Europe, 2008 31
• Figure 3-8 Market Concentration, Orthopedic Biomaterials Market, U.S. 2007 33

COUNTRY PROFILES 35

BONE GRAFT SUBSTITUTE MARKET 48

• Figure 5-1: Total Autograft Procedures, Europe, 2005 - 2015 52
• Figure 5-2 Spine Fusion Procedures, Europe, 2005 - 2015 53
• Figure 5-3: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (€) 55
• Figure 5-4: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (US$) 55
• Figure 5-5 Total Procedures by Indication, Europe, 2005 - 2015 58
• Figure 5-6 Total Utilized Market Value by Indication, Europe, 2005 - 2015 (€) 59
• Figure 5-7 Total Utilized Market Value by Indication, Europe, 2005 - 2015 (US$) 59
• Figure 5-8: Utilized Bone Graft Substitute Market, Europe, 2005 - 2015 (€) 60
• Figure 5-9: Utilized Bone Graft Substitute Market, Europe, 2005 - 2015 (US$) 60
• Figure 5-10: Total Allograft Market, Europe, 2005 - 2015 (€) 62
• Figure 5-11: Total Allograft Market, Europe, 2005 - 2015 (US$) 62
• Figure 5-12: Total DBM Market, Europe, 2005 - 2015 (€) 63
• Figure 5-13: Total DBM Market, Europe, 2005 - 2015 (US$) 63
• Figure 5-14: Total Synthetic Market, Europe, 2005 - 2015 (€) 64
• Figure 5-15: Total Synthetic Market, Europe, 2005 - 2015 (US$) 64
• Figure 5-16: Allograft Spine Market, Europe, 2005 - 2015 (€) 66
• Figure 5-17: Allograft Spine Market, Europe, 2005 - 2015 (US$) 66
• Figure 5-18: DBM Spine Market, Europe, 2005 - 2015 (€) 67
• Figure 5-19: DBM Spine Market, Europe, 2005 - 2015 (US$) 67
• Figure 5-20: Synthetic Spine Market, Europe, 2005 - 2015 (€) 68
• Figure 5-21: Synthetic Spine Market, Europe, 2005 - 2015 (US$) 68
• Figure 5-22: Allograft Cervical Spine Market, Europe, 2005 - 2015 (€) 70
• Figure 5-23: Allograft Cervical Spine Market, Europe, 2005 - 2015 (US$) 70
• Figure 5-24: DBM Cervical Spine Market, Europe, 2005 - 2015 (€) 71
• Figure 5-25: DBM Cervical Spine Market, Europe, 2005 - 2015 (US$) 71
• Figure 5-26: Synthetic Cervical Spine Market, Europe, 2005 - 2015 (€) 72
• Figure 5-27: Synthetic Cervical Spine Market, Europe, 2005 - 2015 (US$) 72
• Figure 5-28: Allograft Thoracolumbar Spine Market, Europe, 2005 - 2015 (€) 74
• Figure 5-29: Allograft Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$) 74
• Figure 5-30: DBM Thoracolumbar Spine Market, Europe, 2005 - 2015 (€) 75
• Figure 5-31: DBM Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$) 75
• Figure 5-32: Synthetic Thoracolumbar Spine Market, Europe, 2005 - 2015 (€) 76
• Figure 5-33: Synthetic Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$)76
• Figure 5-34: Allograft Extremity Market, Europe, 2005 - 2015 (€) 78
• Figure 5-35: Allograft Extremity Market, Europe, 2005 - 2015 (US$) 78
• Figure 5-36: DBM Extremity Market, Europe, 2005 - 2015 (€) 79
• Figure 5-37: DBM Extremity Market, Europe, 2005 - 2015 (US$) 79
• Figure 5-38: Synthetic Extremity Market, Europe, 2005 - 2015 (€) 80
• Figure 5-39: Synthetic Extremity Market, Europe, 2005 - 2015 (US$) 80
• Figure 5-40: Allograft CMF Market, Europe, 2005 - 2015 (€) 82
• Figure 5-41: Allograft CMF Market, Europe, 2005 - 2015 (US$) 82
• Figure 5-42: DBM CMF Market, Europe, 2005 - 2015 (€) 83
• Figure 5-43: DBM CMF Market, Europe, 2005 - 2015 (US$) 83
• Figure 5-44: Synthetic CMF Market, Europe, 2005 - 2015 (€) 84
• Figure 5-45: Synthetic CMF Market, Europe, 2005 - 2015 (US$) 84
• Figure 5-46: Market Drivers and Limiters, Bone Graft Substitute Market, Europe, 2005 - 2015 87
• Figure 5-47: Leading Competitors, Bone Graft Substitute Market, Europe, 2008 90
• Figure 5-48: Leading Competitors in Spinal Fusion Market, Europe, 2008 91
• Figure 5-49: Total Autograft Procedures, Germany, 2005 - 2015 92
• Figure 5-50 Spine Fusion Procedures, Germany, 2005 - 2015 93
• Figure 5-51: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (€) 95
• Figure 5-52: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (US$) 95
• Figure 5-53 Total Procedures by Indication, Germany, 2005 - 2015 96
• Figure 5-54 Total Utilized Market Value by Indication, Germany, 2005 - 2015 (€) 97
• Figure 5-55 Total Utilized Market Value by Indication, Germany, 2005 - 2015 (US$) 97
• Figure 5-56: Utilized Bone Graft Substitute Market, Germany, 2005 - 2015 (€) 98
• Figure 5-57: Utilized Bone Graft Substitute Market, Germany, 2005 - 2015 (US$) 98
• Figure 5-58: Total Allograft Market, Germany, 2005 - 2015 (€) 100
• Figure 5-59: Total Allograft Market, Germany, 2005 - 2015 (US$) 100
• Figure 5-60: Total DBM Market, Germany, 2005 - 2015 (€) 101
• Figure 5-61: Total DBM Market, Germany, 2005 - 2015 (US$) 101
• Figure 5-62: Total Synthetic Market, Germany, 2005 - 2015 (€) 102
• Figure 5-63: Total Synthetic Market, Germany, 2005 - 2015 (US$) 102
• Figure 5-64: Allograft Spine Market, Germany, 2005 - 2015 (€) 104
• Figure 5-65: Allograft Spine Market, Germany, 2005 - 2015 (US$) 104
• Figure 5-66: DBM Spine Market, Germany, 2005 - 2015 (€) 105
• Figure 5-67: DBM Spine Market, Germany, 2005 - 2015 (US$) 105
• Figure 5-68: Synthetic Spine Market, Germany, 2005 - 2015 (€) 106
• Figure 5-69: Synthetic Spine Market, Germany, 2005 - 2015 (US$) 106
• Figure 5-70: Allograft Cervical Spine Market, Germany, 2005 - 2015 (€) 108
• Figure 5-71: Allograft Cervical Spine Market, Germany, 2005 - 2015 (US$) 108
• Figure 5-72: DBM Cervical Spine Market, Germany, 2005 - 2015 (€) 109
• Figure 5-73: DBM Cervical Spine Market, Germany, 2005 - 2015 (US$) 109
• Figure 5-74: Synthetic Cervical Spine Market, Germany, 2005 - 2015 (€) 110
• Figure 5-75: Synthetic Cervical Spine Market, Germany, 2005 - 2015 (US$) 110
• Figure 5-76: Allograft Thoracolumbar Spine Market, Germany, 2005 - 2015 (€) 112
• Figure 5-77: Allograft Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$) 112
• Figure 5-78: DBM Thoracolumbar Spine Market, Germany, 2005 - 2015 (€) 113
• Figure 5-79: DBM Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$) 113
• Figure 5-80: Synthetic Thoracolumbar Spine Market, Germany, 2005 - 2015 (€)114
• Figure 5-81: Synthetic Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$) 114
• Figure 5-82: Allograft Extremity Market, Germany, 2005 - 2015 (€) 116
• Figure 5-83: Allograft Extremity Market, Germany, 2005 - 2015 (US$) 116
• Figure 5-84: DBM Extremity Market, Germany, 2005 - 2015 (€) 117
• Figure 5-85: DBM Extremity Market, Germany, 2005 - 2015 (US$) 117
• Figure 5-86: Synthetic Extremity Market, Germany, 2005 - 2015 (€) 118
• Figure 5-87: Synthetic Extremity Market, Germany, 2005 - 2015 (US$) 118
• Figure 5-88: Allograft CMF Market, Germany, 2005 - 2015 (€) 120
• Figure 5-89: Allograft CMF Market, Germany, 2005 - 2015 (US$) 120
• Figure 5-90: DBM CMF Market, Germany, 2005 - 2015 (€) 121
• Figure 5-91: DBM CMF Market, Germany, 2005 - 2015 (US$) 121
• Figure 5-92: Synthetic CMF Market, Germany, 2005 - 2015 (€) 122
• Figure 5-93: Synthetic CMF Market, Germany, 2005 - 2015 (US$) 122
• Figure 5-94: Market Drivers and Limiters, Germany, Bone Graft Substitute Market, 2005 - 2015 123
• Figure 5-95: Total Autograft Procedures, France, 2005 - 2015 124
• Figure 5-96 Spine Fusion Procedures, France, 2005 - 2015 125
• Figure 5-97: Total Bone Graft Substitute Market, France, 2005 - 2015 (€) 127
• Figure 5-98: Total Bone Graft Substitute Market, France, 2005 - 2015 (US$) 127
• Figure 5-99 Total Procedures by Indication, France, 2005 - 2015 128
• Figure 5-100 Total Utilized Market Value by Indication, France, 2005 - 2015 (€)129
• Figure 5-101 Total Utilized Market Value by Indication, France, 2005 - 2015 (US$) 129
• Figure 5-102: Utilized Bone Graft Substitute Market, France, 2005 - 2015 (€) 130
• Figure 5-103: Utilized Bone Graft Substitute Market, France, 2005 - 2015 (US$)130
• Figure 5-104: Total Allograft Market, France, 2005 - 2015 (€) 132
• Figure 5-105: Total Allograft Market, France, 2005 - 2015 (US$) 132
• Figure 5-106: Total DBM Market, France, 2005 - 2015 (€) 133
• Figure 5-107: Total DBM Market, France, 2005 - 2015 (US$) 133
• Figure 5-108: Total Synthetic Market, France, 2005 - 2015 (€) 134
• Figure 5-109: Total Synthetic Market, France, 2005 - 2015 (US$) 134
• Figure 5-110: Allograft Spine Market, France, 2005 - 2015 (€) 136
• Figure 5-111: Allograft Spine Market, France, 2005 - 2015 (US$) 136
• Figure 5-112: DBM Spine Market, France, 2005 - 2015 (€) 137
• Figure 5-113: DBM Spine Market, France, 2005 - 2015 (US$) 137
• Figure 5-114: Synthetic Spine Market, France, 2005 - 2015 (€) 138
• Figure 5-115: Synthetic Spine Market, France, 2005 - 2015 (US$) 138
• Figure 5-116: Allograft Cervical Spine Market, France, 2005 - 2015 (€) 140
• Figure 5-117: Allograft Cervical Spine Market, France, 2005 - 2015 (US$) 140
• Figure 5-118: DBM Cervical Spine Market, France, 2005 - 2015 (€) 141
• Figure 5-119: DBM Cervical Spine Market, France, 2005 - 2015 (US$) 141
• Figure 5-120: Synthetic Cervical Spine Market, France, 2005 - 2015 (€) 142
• Figure 5-121: Synthetic Cervical Spine Market, France, 2005 - 2015 (US$) 142
• Figure 5-122: Allograft Thoracolumbar Spine Market, France, 2005 - 2015 (€) 144
• Figure 5-123: Allograft Thoracolumbar Spine Market, France, 2005 - 2015 (US$)144
• Figure 5-124: DBM Thoracolumbar Spine Market, France, 2005 - 2015 (€) 145
• Figure 5-125: DBM Thoracolumbar Spine Market, France, 2005 - 2015 (US$) 145
• Figure 5-126: Synthetic Thoracolumbar Spine Market, France, 2005 - 2015 (€) 146
• Figure 5-127: Synthetic Thoracolumbar Spine Market, France, 2005 - 2015 (US$) 146
• Figure 5-128: Allograft Extremity Market, France, 2005 - 2015 (€) 148
• Figure 5-129: Allograft Extremity Market, France, 2005 - 2015 (US$) 148
• Figure 5-130: DBM Extremity Market, France, 2005 - 2015 (€) 149
• Figure 5-131: DBM Extremity Market, France, 2005 - 2015 (US$) 149
• Figure 5-132: Synthetic Extremity Market, France, 2005 - 2015 (€) 150
• Figure 5-133: Synthetic Extremity Market, France, 2005 - 2015 (US$) 150
• Figure 5-134: Allograft CMF Market, France, 2005 - 2015 (€) 152
• Figure 5-135: Allograft CMF Market, France, 2005 - 2015 (US$) 152
• Figure 5-136: DBM CMF Market, France, 2005 - 2015 (€) 153
• Figure 5-137: DBM CMF Market, France, 2005 - 2015 (US$) 153
• Figure 5-138: Synthetic CMF Market, France, 2005 - 2015 (€) 154
• Figure 5-139: Synthetic CMF Market, France, 2005 - 2015 (US$) 154
• Figure 5-140: Market Drivers and Limiters, France, Bone Graft Substitute Market, 2005 - 2015 155
• Figure 5-141: Total Autograft Procedures, U.K., 2005 - 2015 156
• Figure 5-142 Spine Fusion Procedures, U.K., 2005 - 2015 157
• Figure 5-143: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (€) 159
• Figure 5-144: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (US$) 159
• Figure 5-145 Total Procedures by Indication, U.K., 2005 - 2015 160
• Figure 5-146 Total Utilized Market Value by Indication, U.K., 2005 - 2015 (€) 161
• Figure 5-147 Total Utilized Market Value by Indication, U.K., 2005 - 2015 (US$) 161
• Figure 5-148: Utilized Bone Graft Substitute Market, U.K., 2005 - 2015 (€) 162
• Figure 5-149: Utilized Bone Graft Substitute Market, U.K., 2005 - 2015 (US$) 162
• Figure 5-150: Total Allograft Market, U.K., 2005 - 2015 (€) 164
• Figure 5-151: Total Allograft Market, U.K., 2005 - 2015 (US$) 164
• Figure 5-152: Total DBM Market, U.K., 2005 - 2015 (€) 165
• Figure 5-153: Total DBM Market, U.K., 2005 - 2015 (US$) 165
• Figure 5-154: Total Synthetic Market, U.K., 2005 - 2015 (€) 166
• Figure 5-155: Total Synthetic Market, U.K., 2005 - 2015 (US$) 166
• Figure 5-156: Allograft Spine Market, U.K., 2005 - 2015 (€) 168
• Figure 5-157: Allograft Spine Market, U.K., 2005 - 2015 (US$) 168
• Figure 5-158: DBM Spine Market, U.K., 2005 - 2015 (€) 169
• Figure 5-159: DBM Spine Market, U.K., 2005 - 2015 (US$) 169
• Figure 5-160: Synthetic Spine Market, U.K., 2005 - 2015 (€) 170
• Figure 5-161: Synthetic Spine Market, U.K., 2005 - 2015 (US$) 170
• Figure 5-162: Allograft Cervical Spine Market, U.K., 2005 - 2015 (€) 172
• Figure 5-163: Allograft Cervical Spine Market, U.K., 2005 - 2015 (US$) 172
• Figure 5-164: DBM Cervical Spine Market, U.K., 2005 - 2015 (€) 173
• Figure 5-165: DBM Cervical Spine Market, U.K., 2005 - 2015 (US$) 173
• Figure 5-166: Synthetic Cervical Spine Market, U.K., 2005 - 2015 (€) 174
• Figure 5-167: Synthetic Cervical Spine Market, U.K., 2005 - 2015 (US$) 174
• Figure 5-168: Allograft Thoracolumbar Spine Market, U.K., 2005 - 2015 (€) 176
• Figure 5-169: Allograft Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$) 176
• Figure 5-170: DBM Thoracolumbar Spine Market, U.K., 2005 - 2015 (€) 177
• Figure 5-171: DBM Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$) 177
• Figure 5-172: Synthetic Thoracolumbar Spine Market, U.K., 2005 - 2015 (€) 178
• Figure 5-173: Synthetic Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$)178
• Figure 5-174: Allograft Extremity Market, U.K., 2005 - 2015 (€) 180
• Figure 5-175: Allograft Extremity Market, U.K., 2005 - 2015 (US$) 180
• Figure 5-176: DBM Extremity Market, U.K., 2005 - 2015 (€) 181
• Figure 5-177: DBM Extremity Market, U.K., 2005 - 2015 (US$) 181
• Figure 5-178: Synthetic Extremity Market, U.K., 2005 - 2015 (€) 182
• Figure 5-179: Synthetic Extremity Market, U.K., 2005 - 2015 (US$) 182
• Figure 5-180: Allograft CMF Market, U.K., 2005 - 2015 (€) 184
• Figure 5-181: Allograft CMF Market, U.K., 2005 - 2015 (US$) 184
• Figure 5-182: DBM CMF Market, U.K., 2005 - 2015 (€) 185
• Figure 5-183: DBM CMF Market, U.K., 2005 - 2015 (US$) 185
• Figure 5-184: Synthetic CMF Market, U.K., 2005 - 2015 (€) 186
• Figure 5-185: Synthetic CMF Market, U.K., 2005 - 2015 (US$) 186
• Figure 5-186: Market Drivers and Limiters, U.K., Bone Graft Substitute Market, 2005 - 2015 187
• Figure 5-187: Total Autograft Procedures, Spain, 2005 - 2015 188
• Figure 5-188 Spine Fusion Procedures, Spain, 2005 - 2015 189
• Figure 5-189: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (€) 191
• Figure 5-190: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (US$) 191
• Figure 5-191 Total Procedures by Indication, Spain, 2005 - 2015 192
• Figure 5-192 Total Utilized Market Value by Indication, Spain, 2005 - 2015 (€)193
• Figure 5-193 Total Utilized Market Value by Indication, Spain, 2005 - 2015 (US$) 193
• Figure 5-194: Utilized Bone Graft Substitute Market, Spain, 2005 - 2015 (€) 194
• Figure 5-195: Utilized Bone Graft Substitute Market, Spain, 2005 - 2015 (US$) 194
• Figure 5-196: Total Allograft Market, Spain, 2005 - 2015 (€) 196
• Figure 5-197: Total Allograft Market, Spain, 2005 - 2015 (US$) 196
• Figure 5-198: Total DBM Market, Spain, 2005 - 2015 (€) 197
• Figure 5-199: Total DBM Market, Spain, 2005 - 2015 (US$) 197
• Figure 5-200: Total Synthetic Market, Spain, 2005 - 2015 (€) 198
• Figure 5-201: Total Synthetic Market, Spain, 2005 - 2015 (US$) 198
• Figure 5-202: Allograft Spine Market, Spain, 2005 - 2015 (€) 200
• Figure 5-203: Allograft Spine Market, Spain, 2005 - 2015 (US$) 200
• Figure 5-204: DBM Spine Market, Spain, 2005 - 2015 (€) 201
• Figure 5-205: DBM Spine Market, Spain, 2005 - 2015 (US$) 201
• Figure 5-206: Synthetic Spine Market, Spain, 2005 - 2015 (€) 202
• Figure 5-207: Synthetic Spine Market, Spain, 2005 - 2015 (US$) 202
• Figure 5-208: Allograft Cervical Spine Market, Spain, 2005 - 2015 (€) 204
• Figure 5-209: Allograft Cervical Spine Market, Spain, 2005 - 2015 (US$) 204
• Figure 5-210: DBM Cervical Spine Market, Spain, 2005 - 2015 (€) 205
• Figure 5-211: DBM Cervical Spine Market, Spain, 2005 - 2015 (US$) 205
• Figure 5-212: Synthetic Cervical Spine Market, Spain, 2005 - 2015 (€) 206
• Figure 5-213: Synthetic Cervical Spine Market, Spain, 2005 - 2015 (US$) 206
• Figure 5-214: Allograft Thoracolumbar Spine Market, Spain, 2005 - 2015 (€) 208
• Figure 5-215: Allograft Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$)208
• Figure 5-216: DBM Thoracolumbar Spine Market, Spain, 2005 - 2015 (€) 209
• Figure 5-217: DBM Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$) 209
• Figure 5-218: Synthetic Thoracolumbar Spine Market, Spain, 2005 - 2015 (€) 210
• Figure 5-219: Synthetic Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$)210
• Figure 5-220: Allograft Extremity Market, Spain, 2005 - 2015 (€) 212
• Figure 5-221: Allograft Extremity Market, Spain, 2005 - 2015 (US$) 212
• Figure 5-222: DBM Extremity Market, Spain, 2005 - 2015 (€) 213
• Figure 5-223: DBM Extremity Market, Spain, 2005 - 2015 (US$) 213
• Figure 5-224: Synthetic Extremity Market, Spain, 2005 - 2015 (€) 214
• Figure 5-225: Synthetic Extremity Market, Spain, 2005 - 2015 (US$) 214
• Figure 5-226: Allograft CMF Market, Spain, 2005 - 2015 (€) 216
• Figure 5-227: Allograft CMF Market, Spain, 2005 - 2015 (US$) 216
• Figure 5-228: DBM CMF Market, Spain, 2005 - 2015 (€) 217
• Figure 5-229: DBM CMF Market, Spain, 2005 - 2015 (US$) 217
• Figure 5-230: Synthetic CMF Market, Spain, 2005 - 2015 (€) 218
• Figure 5-231: Synthetic CMF Market, Spain, 2005 - 2015 (US$) 218
• Figure 5-232: Market Drivers and Limiters, Spain, Bone Graft Substitute Market, 2005 - 2015 219
• Figure 5-233: Total Autograft Procedures, Italy, 2005 - 2015 220
• Figure 5-234 Spine Fusion Procedures, Italy, 2005 - 2015 221
• Figure 5-235: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (€) 223
• Figure 5-236: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (US$) 223
• Figure 5-237 Total Procedures by Indication, Italy, 2005 - 2015 224
• Figure 5-238 Total Utilized Market Value by Indication, Italy, 2005 - 2015 (€) 225
• Figure 5-239 Total Utilized Market Value by Indication, Italy, 2005 - 2015 (US$) 225
• Figure 5-240: Utilized Bone Graft Substitute Market, Italy, 2005 - 2015 (€) 226
• Figure 5-241: Utilized Bone Graft Substitute Market, Italy, 2005 - 2015 (US$) 226
• Figure 5-242: Total Allograft Market, Italy, 2005 - 2015 (€) 228
• Figure 5-243: Total Allograft Market, Italy, 2005 - 2015 (US$) 228
• Figure 5-244: Total DBM Market, Italy, 2005 - 2015 (€) 229
• Figure 5-245: Total DBM Market, Italy, 2005 - 2015 (US$) 229
• Figure 5-246: Total Synthetic Market, Italy, 2005 - 2015 (€) 230
• Figure 5-247: Total Synthetic Market, Italy, 2005 - 2015 (US$) 230
• Figure 5-248: Allograft Spine Market, Italy, 2005 - 2015 (€) 232
• Figure 5-249: Allograft Spine Market, Italy, 2005 - 2015 (US$) 232
• Figure 5-250: DBM Spine Market, Italy, 2005 - 2015 (€) 233
• Figure 5-251: DBM Spine Market, Italy, 2005 - 2015 (US$) 233
• Figure 5-252: Synthetic Spine Market, Italy, 2005 - 2015 (€) 234
• Figure 5-253: Synthetic Spine Market, Italy, 2005 - 2015 (US$) 234
• Figure 5-254: Allograft Cervical Spine Market, Italy, 2005 - 2015 (€) 236
• Figure 5-255: Allograft Cervical Spine Market, Italy, 2005 - 2015 (US$) . 236
• Figure 5-256: DBM Cervical Spine Market, Italy, 2005 - 2015 (€) 237
• Figure 5-257: DBM Cervical Spine Market, Italy, 2005 - 2015 (US$) 237
• Figure 5-258: Synthetic Cervical Spine Market, Italy, 2005 - 2015 (€) 238
• Figure 5-259: Synthetic Cervical Spine Market, Italy, 2005 - 2015 (US$) 238
• Figure 5-260: Allograft Thoracolumbar Spine Market, Italy, 2005 - 2015 (€) 240
• Figure 5-261: Allograft Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$) 240
• Figure 5-262: DBM Thoracolumbar Spine Market, Italy, 2005 - 2015 (€) . 241
• Figure 5-263: DBM Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$) 241
• Figure 5-264: Synthetic Thoracolumbar Spine Market, Italy, 2005 - 2015 (€) 242
• Figure 5-265: Synthetic Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$)242
• Figure 5-266: Allograft Extremity Market, Italy, 2005 - 2015 (€) 244
• Figure 5-267: Allograft Extremity Market, Italy, 2005 - 2015 (US$) 244
• Figure 5-268: DBM Extremity Market, Italy, 2005 - 2015 (€) 245
• Figure 5-269: DBM Extremity Market, Italy, 2005 - 2015 (US$) 245
• Figure 5-270: Synthetic Extremity Market, Italy, 2005 - 2015 (€) 246
• Figure 5-271: Synthetic Extremity Market, Italy, 2005 - 2015 (US$) 246
• Figure 5-272: Allograft CMF Market, Italy, 2005 - 2015 (€) 248
• Figure 5-273: Allograft CMF Market, Italy, 2005 - 2015 (US$) 248
• Figure 5-274: DBM CMF Market, Italy, 2005 - 2015 (€) 249
• Figure 5-275: DBM CMF Market, Italy, 2005 - 2015 (US$) 249
• Figure 5-276: Synthetic CMF Market, Italy, 2005 - 2015 (€) 250
• Figure 5-277: Synthetic CMF Market, Italy, 2005 - 2015 (US$) 250
• Figure 5-278: Market Drivers and Limiters, Italy, Bone Graft Substitute Market, 2005 - 2015 251
• Figure 5-279: Total Autograft Procedures, Benelux, 2005 - 2015 252
• Figure 5-280 Spine Fusion Procedures, Benelux, 2005 - 2015 253
• Figure 5-281: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (€) 255
• Figure 5-282: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (US$) 255
• Figure 5-283 Total Procedures by Indication, Benelux, 2005 - 2015 256
• Figure 5-284 Total Utilized Market Value by Indication, Benelux, 2005 - 2015 (€) 257
• Figure 5-285 Total Utilized Market Value by Indication, Benelux, 2005 - 2015 (US$) 257
• Figure 5-286: Utilized Bone Graft Substitute Market, Benelux, 2005 - 2015 (€) 258
• Figure 5-287: Utilized Bone Graft Substitute Market, Benelux, 2005 - 2015 (US$) 258
• Figure 5-288: Total Allograft Market, Benelux, 2005 - 2015 (€) 260
• Figure 5-289: Total Allograft Market, Benelux, 2005 - 2015 (US$) 260
• Figure 5-290: Total DBM Market, Benelux, 2005 - 2015 (€) 261
• Figure 5-291: Total DBM Market, Benelux, 2005 - 2015 (US$) 261
• Figure 5-292: Total Synthetic Market, Benelux, 2005 - 2015 (€) 262
• Figure 5-293: Total Synthetic Market, Benelux, 2005 - 2015 (US$) 262
• Figure 5-294: Allograft Spine Market, Benelux, 2005 - 2015 (€) 264
• Figure 5-295: Allograft Spine Market, Benelux, 2005 - 2015 (US$) 264
• Figure 5-296: DBM Spine Market, Benelux, 2005 - 2015 (€) 265
• Figure 5-297: DBM Spine Market, Benelux, 2005 - 2015 (US$) 265
• Figure 5-298: Synthetic Spine Market, Benelux, 2005 - 2015 (€) 266
• Figure 5-299: Synthetic Spine Market, Benelux, 2005 - 2015 (US$) 266
• Figure 5-300: Allograft Cervical Spine Market, Benelux, 2005 - 2015 (€) 268
• Figure 5-301: Allograft Cervical Spine Market, Benelux, 2005 - 2015 (US$) 268
• Figure 5-302: DBM Cervical Spine Market, Benelux, 2005 - 2015 (€) 269
• Figure 5-303: DBM Cervical Spine Market, Benelux, 2005 - 2015 (US$) 269
• Figure 5-304: Synthetic Cervical Spine Market, Benelux, 2005 - 2015 (€) 270
• Figure 5-305: Synthetic Cervical Spine Market, Benelux, 2005 - 2015 (US$) 270
• Figure 5-306: Allograft Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€)272
• Figure 5-307: Allograft Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$) 272
• Figure 5-308: DBM Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€) 273
• Figure 5-309: DBM Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$) 273
• Figure 5-310: Synthetic Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€)274
• Figure 5-311: Synthetic Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$) 274
• Figure 5-312: Allograft Extremity Market, Benelux, 2005 - 2015 (€) 276
• Figure 5-313: Allograft Extremity Market, Benelux, 2005 - 2015 (US$) 276
• Figure 5-314: DBM Extremity Market, Benelux, 2005 - 2015 (€) 277
• Figure 5-315: DBM Extremity Market, Benelux, 2005 - 2015 (US$) 277
• Figure 5-316: Synthetic Extremity Market, Benelux, 2005 - 2015 (€) 278
• Figure 5-317: Synthetic Extremity Market, Benelux, 2005 - 2015 (US$) 278
• Figure 5-318: Allograft CMF Market, Benelux, 2005 - 2015 (€) 280
• Figure 5-319: Allograft CMF Market, Benelux, 2005 - 2015 (US$) 280
• Figure 5-320: DBM CMF Market, Benelux, 2005 - 2015 (€) 281
• Figure 5-321: DBM CMF Market, Benelux, 2005 - 2015 (US$) 281
• Figure 5-322: Synthetic CMF Market, Benelux, 2005 - 2015 (€) 282
• Figure 5-323: Synthetic CMF Market, Benelux, 2005 - 2015 (US$) 282
• Figure 5-324: Market Drivers and Limiters, Benelux, Bone Graft Substitute Market, 2005 - 2015 283
• Figure 5-325: Total Autograft Procedures, Scandinavia, 2005 - 2015 284
• Figure 5-326 Spine Fusion Procedures, Scandinavia, 2005 - 2015 285
• Figure 5-327: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€)287
• Figure 5-328: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (US$) 287
• Figure 5-329 Total Procedures by Indication, Scandinavia, 2005 - 2015 288
• Figure 5-330 Total Utilized Market Value by Indication, Scandinavia, 2005 - 2015 (€) 289
• Figure 5-331 Total Utilized Market Value by Indication, Scandinavia, 2005 - 2015 (US$) 289
• Figure 5-332: Utilized Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€) 290
• Figure 5-333: Utilized Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (US$) 290
• Figure 5-334: Total Allograft Market, Scandinavia, 2005 - 2015 (€) 292
• Figure 5-335: Total Allograft Market, Scandinavia, 2005 - 2015 (US$) 292
• Figure 5-336: Total DBM Market, Scandinavia, 2005 - 2015 (€) 293
• Figure 5-337: Total DBM Market, Scandinavia, 2005 - 2015 (US$) 293
• Figure 5-338: Total Synthetic Market, Scandinavia, 2005 - 2015 (€) 294
• Figure 5-339: Total Synthetic Market, Scandinavia, 2005 - 2015 (US$) 294
• Figure 5-340: Allograft Spine Market, Scandinavia, 2005 - 2015 (€) 296
• Figure 5-341: Allograft Spine Market, Scandinavia, 2005 - 2015 (US$) 296
• Figure 5-342: DBM Spine Market, Scandinavia, 2005 - 2015 (€) 297
• Figure 5-343: DBM Spine Market, Scandinavia, 2005 - 2015 (US$) 297
• Figure 5-344: Synthetic Spine Market, Scandinavia, 2005 - 2015 (€) 298
• Figure 5-345: Synthetic Spine Market, Scandinavia, 2005 - 2015 (US$) 298
• Figure 5-346: Allograft Cervical Spine Market, Scandinavia, 2005 - 2015 (€) 300
• Figure 5-347: Allograft Cervical Spine Market, Scandinavia, 2005 - 2015 (US$)300
• Figure 5-348: DBM Cervical Spine Market, Scandinavia, 2005 - 2015 (€) 301
• Figure 5-349: DBM Cervical Spine Market, Scandinavia, 2005 - 2015 (US$) 301
• Figure 5-350: Synthetic Cervical Spine Market, Scandinavia, 2005 - 2015 (€) 302
• Figure 5-351: Synthetic Cervical Spine Market, Scandinavia, 2005 - 2015 (US$)302
• Figure 5-352: Allograft Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€) 304
• Figure 5-353: Allograft Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$) 304
• Figure 5-354: DBM Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€)305
• Figure 5-355: DBM Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$) 305
• Figure 5-356: Synthetic Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€) 306
• Figure 5-357: Synthetic Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$) 306
• Figure 5-358: Allograft Extremity Market, Scandinavia, 2005 - 2015 (€) 308
• Figure 5-359: Allograft Extremity Market, Scandinavia, 2005 - 2015 (US$) 308
• Figure 5-360: DBM Extremity Market, Scandinavia, 2005 - 2015 (€) 309
• Figure 5-361: DBM Extremity Market, Scandinavia, 2005 - 2015 (US$) 309
• Figure 5-362: Synthetic Extremity Market, Scandinavia, 2005 - 2015 (€) 310
• Figure 5-363: Synthetic Extremity Market, Scandinavia, 2005 - 2015 (US$) 310
• Figure 5-364: Allograft CMF Market, Scandinavia, 2005 - 2015 (€) 312
• Figure 5-365: Allograft CMF Market, Scandinavia, 2005 - 2015 (US$) 312
• Figure 5-366: DBM CMF Market, Scandinavia, 2005 - 2015 (€) 313
• Figure 5-367: DBM CMF Market, Scandinavia, 2005 - 2015 (US$) 313
• Figure 5-368: Synthetic CMF Market, Scandinavia, 2005 - 2015 (€) 314
• Figure 5-369: Synthetic CMF Market, Scandinavia, 2005 - 2015 (US$) 314
• Figure 5-370: Market Drivers and Limiters, Scandinavia, Bone Graft Substitute Market, 2005 - 2015 316
• Figure 5-371: Total Autograft Procedures, Switzerland, 2005 - 2015 317
• Figure 5-372 Spine Fusion Procedures, Switzerland, 2005 - 2015 318
• Figure 5-373: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€)320
• Figure 5-374: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (US$) 320
• Figure 5-375 Total Procedures by Indication, Switzerland, 2005 - 2015 321
• Figure 5-376 Total Utilized Market Value by Indication, Switzerland, 2005 - 2015 (€) 322
• Figure 5-377 Total Utilized Market Value by Indication, Switzerland, 2005 - 2015 (US$) 322
• Figure 5-378: Utilized Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€) 323
• Figure 5-379: Utilized Bone Graft Substitute Market, Switzerland, 2005 - 2015 (US$) 323
• Figure 5-380: Total Allograft Market, Switzerland, 2005 - 2015 (€) 325
• Figure 5-381: Total Allograft Market, Switzerland, 2005 - 2015 (US$) 325
• Figure 5-382: Total DBM Market, Switzerland, 2005 - 2015 (€) 326
• Figure 5-383: Total DBM Market, Switzerland, 2005 - 2015 (US$) 326
• Figure 5-384: Total Synthetic Market, Switzerland, 2005 - 2015 (€) 327
• Figure 5-385: Total Synthetic Market, Switzerland, 2005 - 2015 (US$) 327
• Figure 5-386: Allograft Spine Market, Switzerland, 2005 - 2015 (€) 329
• Figure 5-387: Allograft Spine Market, Switzerland, 2005 - 2015 (US$) 329
• Figure 5-388: DBM Spine Market, Switzerland, 2005 - 2015 (€) 330
• Figure 5-389: DBM Spine Market, Switzerland, 2005 - 2015 (US$) 330
• Figure 5-390: Synthetic Spine Market, Switzerland, 2005 - 2015 (€) 331
• Figure 5-391: Synthetic Spine Market, Switzerland, 2005 - 2015 (US$) 331
• Figure 5-392: Allograft Cervical Spine Market, Switzerland, 2005 - 2015 (€) 333
• Figure 5-393: Allograft Cervical Spine Market, Switzerland, 2005 - 2015 (US$)333
• Figure 5-394: DBM Cervical Spine Market, Switzerland, 2005 - 2015 (€) 334
• Figure 5-395: DBM Cervical Spine Market, Switzerland, 2005 - 2015 (US$) 334
• Figure 5-396: Synthetic Cervical Spine Market, Switzerland, 2005 - 2015 (€) 335
• Figure 5-397: Synthetic Cervical Spine Market, Switzerland, 2005 - 2015 (US$)335
• Figure 5-398: Allograft Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€) 337
• Figure 5-399: Allograft Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$) 337
• Figure 5-400: DBM Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€)338
• Figure 5-401: DBM Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$) 338
• Figure 5-402: Synthetic Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€) 339
• Figure 5-403: Synthetic Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$) 339
• Figure 5-404: Allograft Extremity Market, Switzerland, 2005 - 2015 (€) 341
• Figure 5-405: Allograft Extremity Market, Switzerland, 2005 - 2015 (US$) 341
• Figure 5-406: DBM Extremity Market, Switzerland, 2005 - 2015 (€) 342
• Figure 5-407: DBM Extremity Market, Switzerland, 2005 - 2015 (US$) 342
• Figure 5-408: Synthetic Extremity Market, Switzerland, 2005 - 2015 (€) 343
• Figure 5-409: Synthetic Extremity Market, Switzerland, 2005 - 2015 (US$) 343
• Figure 5-410: Allograft CMF Market, Switzerland, 2005 - 2015 (€) 345
• Figure 5-411: Allograft CMF Market, Switzerland, 2005 - 2015 (US$) 345
• Figure 5-412: DBM CMF Market, Switzerland, 2005 - 2015 (€) 346
• Figure 5-413: DBM CMF Market, Switzerland, 2005 - 2015 (US$) 346
• Figure 5-414: Synthetic CMF Market, Switzerland, 2005 - 2015 (€) 347
• Figure 5-415: Synthetic CMF Market, Switzerland, 2005 - 2015 (US$) 347
• Figure 5-416: Market Drivers and Limiters, Switzerland, Bone Graft Substitute Market, 2005 - 2015 348
• Figure 5-417: Total Autograft Procedures, Austria, 2005 - 2015 349
• Figure 5-418 Spine Fusion Procedures, Austria, 2005 - 2015 350
• Figure 5-419: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (€) 352
• Figure 5-420: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (US$) . 352
• Figure 5-421 Total Procedures by Indication, Austria, 2005 - 2015 353
• Figure 5-422 Total Utilized Market Value by Indication, Austria, 2005 - 2015 (€)354
• Figure 5-423 Total Utilized Market Value by Indication, Austria, 2005 - 2015 (US$) 354
• Figure 5-424: Utilized Bone Graft Substitute Market, Austria, 2005 - 2015 (€) . 355
• Figure 5-425: Utilized Bone Graft Substitute Market, Austria, 2005 - 2015 (US$)355
• Figure 5-426: Total Allograft Market, Austria, 2005 - 2015 (€) 357
• Figure 5-427: Total Allograft Market, Austria, 2005 - 2015 (US$) 357
• Figure 5-428: Total DBM Market, Austria, 2005 - 2015 (€) 358
• Figure 5-429: Total DBM Market, Austria, 2005 - 2015 (US$) 358
• Figure 5-430: Total Synthetic Market, Austria, 2005 - 2015 (€) 359
• Figure 5-431: Total Synthetic Market, Austria, 2005 - 2015 (US$) 359
• Figure 5-432: Allograft Spine Market, Austria, 2005 - 2015 (€) 361
• Figure 5-433: Allograft Spine Market, Austria, 2005 - 2015 (US$) 361
• Figure 5-434: DBM Spine Market, Austria, 2005 - 2015 (€) 362
• Figure 5-435: DBM Spine Market, Austria, 2005 - 2015 (US$) 362
• Figure 5-436: Synthetic Spine Market, Austria, 2005 - 2015 (€) 363
• Figure 5-437: Synthetic Spine Market, Austria, 2005 - 2015 (US$) 363
• Figure 5-438: Allograft Cervical Spine Market, Austria, 2005 - 2015 (€) 365
• Figure 5-439: Allograft Cervical Spine Market, Austria, 2005 - 2015 (US$) 365
• Figure 5-440: DBM Cervical Spine Market, Austria, 2005 - 2015 (€) 366
• Figure 5-441: DBM Cervical Spine Market, Austria, 2005 - 2015 (US$) 366
• Figure 5-442: Synthetic Cervical Spine Market, Austria, 2005 - 2015 (€) 367
• Figure 5-443: Synthetic Cervical Spine Market, Austria, 2005 - 2015 (US$) 367
• Figure 5-444: Allograft Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 369
• Figure 5-445: Allograft Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$) 369
• Figure 5-446: DBM Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 370
• Figure 5-447: DBM Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$) 370
• Figure 5-448: Synthetic Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 371
• Figure 5-449: Synthetic Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$) 371
• Figure 5-450: Allograft Extremity Market, Austria, 2005 - 2015 (€) 373
• Figure 5-451: Allograft Extremity Market, Austria, 2005 - 2015 (US$) 373
• Figure 5-452: DBM Extremity Market, Austria, 2005 - 2015 (€) 374
• Figure 5-453: DBM Extremity Market, Austria, 2005 - 2015 (US$) 374
• Figure 5-454: Synthetic Extremity Market, Austria, 2005 - 2015 (€) 375
• Figure 5-455: Synthetic Extremity Market, Austria, 2005 - 2015 (US$) 375
• Figure 5-456: Allograft CMF Market, Austria, 2005 - 2015 (€) 377
• Figure 5-457: Allograft CMF Market, Austria, 2005 - 2015 (US$) 377
• Figure 5-458: DBM CMF Market, Austria, 2005 - 2015 (€) 378
• Figure 5-459: DBM CMF Market, Austria, 2005 - 2015 (US$) 378
• Figure 5-460: Synthetic CMF Market, Austria, 2005 - 2015 (€) 379
• Figure 5-461: Synthetic CMF Market, Austria, 2005 - 2015 (US$) 379
• Figure 5-462: Market Drivers and Limiters, Austria, Bone Graft Substitute Market, 2005 - 2015 380
• Figure 5-463: Total Autograft Procedures, Portugal, 2005 - 2015 381
• Figure 5-464 Spine Fusion Procedures, Portugal, 2005 - 2015 382
• Figure 5-465: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (€) 384
• Figure 5-466: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (US$) 384
• Figure 5-467 Total Procedures by Indication, Portugal, 2005 - 2015 385
• Figure 5-468 Total Utilized Market Value by Indication, Portugal, 2005 - 2015 (€) 386
• Figure 5-469 Total Utilized Market Value by Indication, Portugal, 2005 - 2015 (US$) 386
• Figure 5-470: Utilized Bone Graft Substitute Market, Portugal, 2005 - 2015 (€) 387
• Figure 5-471: Utilized Bone Graft Substitute Market, Portugal, 2005 - 2015 (US$) 387
• Figure 5-472: Total Allograft Market, Portugal, 2005 - 2015 (€) 389
• Figure 5-473: Total Allograft Market, Portugal, 2005 - 2015 (US$) 389
• Figure 5-474: Total DBM Market, Portugal, 2005 - 2015 (€) 390
• Figure 5-475: Total DBM Market, Portugal, 2005 - 2015 (US$) 390
• Figure 5-476: Total Synthetic Market, Portugal, 2005 - 2015 (€) 391
• Figure 5-477: Total Synthetic Market, Portugal, 2005 - 2015 (US$) 391
• Figure 5-478: Allograft Spine Market, Portugal, 2005 - 2015 (€) 393
• Figure 5-479: Allograft Spine Market, Portugal, 2005 - 2015 (US$) 393
• Figure 5-480: DBM Spine Market, Portugal, 2005 - 2015 (€) 394
• Figure 5-481: DBM Spine Market, Portugal, 2005 - 2015 (US$) 394
• Figure 5-482: Synthetic Spine Market, Portugal, 2005 - 2015 (€) 395
• Figure 5-483: Synthetic Spine Market, Portugal, 2005 - 2015 (US$) 395
• Figure 5-484: Allograft Cervical Spine Market, Portugal, 2005 - 2015 (€) 397
• Figure 5-485: Allograft Cervical Spine Market, Portugal, 2005 - 2015 (US$) 397
• Figure 5-486: DBM Cervical Spine Market, Portugal, 2005 - 2015 (€) 398
• Figure 5-487: DBM Cervical Spine Market, Portugal, 2005 - 2015 (US$) 398
• Figure 5-488: Synthetic Cervical Spine Market, Portugal, 2005 - 2015 (€) 399
• Figure 5-489: Synthetic Cervical Spine Market, Portugal, 2005 - 2015 (US$) 399
• Figure 5-490: Allograft Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€)401
• Figure 5-491: Allograft Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$) 401
• Figure 5-492: DBM Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€) 402
• Figure 5-493: DBM Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$) 402
• Figure 5-494: Synthetic Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€)403
• Figure 5-495: Synthetic Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$) 403
• Figure 5-496: Allograft Extremity Market, Portugal, 2005 - 2015 (€) 405
• Figure 5-497: Allograft Extremity Market, Portugal, 2005 - 2015 (US$) 405
• Figure 5-498: DBM Extremity Market, Portugal, 2005 - 2015 (€) 406
• Figure 5-499: DBM Extremity Market, Portugal, 2005 - 2015 (US$) 406
• Figure 5-500: Synthetic Extremity Market, Portugal, 2005 - 2015 (€) 407
• Figure 5-501: Synthetic Extremity Market, Portugal, 2005 - 2015 (US$) 407
• Figure 5-502: Allograft CMF Market, Portugal, 2005 - 2015 (€) 409
• Figure 5-503: Allograft CMF Market, Portugal, 2005 - 2015 (US$) 409
• Figure 5-504: DBM CMF Market, Portugal, 2005 - 2015 (€) 410
• Figure 5-505: DBM CMF Market, Portugal, 2005 - 2015 (US$) 410
• Figure 5-506: Synthetic CMF Market, Portugal, 2005 - 2015 (€) 411
• Figure 5-507: Synthetic CMF Market, Portugal, 2005 - 2015 (US$) 411
• Figure 5-508: Market Drivers and Limiters, Portugal, Bone Graft Substitute Market, 2005 - 2015 412
• Figure 5-509: Total Autograft Procedures, Greece, 2005 - 2015 413
• Figure 5-510 Spine Fusion Procedures, Greece, 2005 - 2015 414
• Figure 5-511: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (€) 416
• Figure 5-512: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (US$) 416
• Figure 5-513 Total Procedures by Indication, Greece, 2005 - 2015 417
• Figure 5-514 Total Utilized Market Value by Indication, Greece, 2005 - 2015 (€)418
• Figure 5-515 Total Utilized Market Value by Indication, Greece, 2005 - 2015 (US$) 418
• Figure 5-516: Utilized Bone Graft Substitute Market, Greece, 2005 - 2015 (€) 419
• Figure 5-517: Utilized Bone Graft Substitute Market, Greece, 2005 - 2015 (US$)419
• Figure 5-518: Total Allograft Market, Greece, 2005 - 2015 (€) 421
• Figure 5-519: Total Allograft Market, Greece, 2005 - 2015 (US$) 421
• Figure 5-520: Total DBM Market, Greece, 2005 - 2015 (€) 422
• Figure 5-521: Total DBM Market, Greece, 2005 - 2015 (US$) 422
• Figure 5-522: Total Synthetic Market, Greece, 2005 - 2015 (€) 423
• Figure 5-523: Total Synthetic Market, Greece, 2005 - 2015 (US$) 423
• Figure 5-524: Allograft Spine Market, Greece, 2005 - 2015 (€) 425
• Figure 5-525: Allograft Spine Market, Greece, 2005 - 2015 (US$) 425
• Figure 5-526: DBM Spine Market, Greece, 2005 - 2015 (€) 426
• Figure 5-527: DBM Spine Market, Greece, 2005 - 2015 (US$) 426
• Figure 5-528: Synthetic Spine Market, Greece, 2005 - 2015 (€) 427
• Figure 5-529: Synthetic Spine Market, Greece, 2005 - 2015 (US$) 427
• Figure 5-530: Allograft Cervical Spine Market, Greece, 2005 - 2015 (€) 429
• Figure 5-531: Allograft Cervical Spine Market, Greece, 2005 - 2015 (US$) 429
• Figure 5-532: DBM Cervical Spine Market, Greece, 2005 - 2015 (€) 430
• Figure 5-533: DBM Cervical Spine Market, Greece, 2005 - 2015 (US$) 430
• Figure 5-534: Synthetic Cervical Spine Market, Greece, 2005 - 2015 (€) 431
• Figure 5-535: Synthetic Cervical Spine Market, Greece, 2005 - 2015 (US$) 431
• Figure 5-536: Allograft Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 433
• Figure 5-537: Allograft Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$) 433
• Figure 5-538: DBM Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 434
• Figure 5-539: DBM Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$) 434
• Figure 5-540: Synthetic Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 435
• Figure 5-541: Synthetic Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$) 435
• Figure 5-542: Allograft Extremity Market, Greece, 2005 - 2015 (€) 437
• Figure 5-543: Allograft Extremity Market, Greece, 2005 - 2015 (US$) 437
• Figure 5-544: DBM Extremity Market, Greece, 2005 - 2015 (€) 438
• Figure 5-545: DBM Extremity Market, Greece, 2005 - 2015 (US$) 438
• Figure 5-546: Synthetic Extremity Market, Greece, 2005 - 2015 (€) 439
• Figure 5-547: Synthetic Extremity Market, Greece, 2005 - 2015 (US$) 439
• Figure 5-548: Allograft CMF Market, Greece, 2005 - 2015 (€) 441
• Figure 5-549: Allograft CMF Market, Greece, 2005 - 2015 (US$) 441
• Figure 5-550: DBM CMF Market, Greece, 2005 - 2015 (€) 442
• Figure 5-551: DBM CMF Market, Greece, 2005 - 2015 (US$) 442
• Figure 5-552: Synthetic CMF Market, Greece, 2005 - 2015 (€) 443
• Figure 5-553: Synthetic CMF Market, Greece, 2005 - 2015 (US$) 443
• Figure 5-554: Market Drivers and Limiters, Greece, Bone Graft Substitute Market, 2005 - 2015 444

BMP GROWTH FACTOR MARKET 445

• Figure 6-1: Orthopedic Growth Factor Market, Europe, 2005 - 2015 (€) 448
• Figure 6-2: Orthopedic Growth Factor Market, Europe, 2005 - 2015 ($US) 448
• Figure 6-3: Drivers and Limiters, Orthopedic Growth Factor Market, Europe, 2005 - 2015 450
• Figure 6-4: Leading Competitors, Orthopedic Growth Factor Market, Europe, 2008 451

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 454

• Figure 7-1: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 457
• Figure 7-2: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 457
• Figure 7-3: Single-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 459
• Figure 7-4: Single-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 459
• Figure 7-5: Three-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 461
• Figure 7-6: Three-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 461
• Figure 7-7: Five-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 463
• Figure 7-8: Five-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 463
• Figure 7-9: Hyaluronic Acid Viscosupplementation Injections per Country, Europe, 2008 464
• Figure 7-10: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 466
• Figure 7-11: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2008 468

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 470

• Figure 8-1: ACI Market, Europe, 2005 - 2015 (€) 473
• Figure 8-2: ACI Market, Europe, 2005 - 2015 ($US) 473
• Figure 8-3: Drivers and Limiters, ACI Market, Europe, 2005 - 2015 474
• Figure 8-4: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2008 477
• Figure 8-5: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2008 477

PLATELET AND BONE MARROW CONCENTRATION MARKET 478

• Figure 9-1: Total Cell Concentration Market, Europe, 2005 - 2015 (€) 481
• Figure 9-2: Total Cell Concentration Market, Europe, 2005 - 2015 (€) 482
• Figure 9-3: Total Cell Concentration Market, Europe, 2005 - 2015 ($US) 482
• Figure 9-4: Platelet Concentration Market, Europe, 2005 - 2015 (€) 484
• Figure 9-5: Platelet Concentration Market, Europe, 2005 - 2015 ($US) 484
• Figure 9-6: Bone Marrow Concentration Market, Europe, 2005 - 2015 (€) 486
• Figure 9-7: Bone Marrow Concentration Market, Europe, 2005 - 2015 ($US) 486
• Figure 9-8: Drivers and Limiters, Platelet and Bone Marrow Concentration Market, Europe, 2005 - 2015 488
• Figure 9-9: Leading Competitors, Platelet and Bone Marrow Concentration Market, Europe, 2008 489

ABBREVIATIONS 491

APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES 492

• Figure 11-1: Combined Joint Revision Procedures, Europe, 2005 - 2015 493
• Figure 11-2: Hip Joint Revision Procedures, Europe, 2005 - 2015 494
• Figure 11-3: Knee Joint Revision Procedures, Europe, 2005 - 2015 495

LIST OF CHARTS

EXECUTIVE SUMMARY 1

• Chart 1-1: Total Biomaterial Market, Europe, 2005 - 2015 (€) 1
• Chart 1-2: Autograft Procedures, Europe, 2008 2
• Chart 1-3: BGS Units, Used and Unused, Europe, 2005 - 2015 3
• Chart 1-4: Units Implanted, Bone Graft Substitute Market, Europe, 2008 4
• Chart 1-5: Hyaluronic Viscosupplementation Procedures, Europe, 2005 - 2015 5
• Chart 1-6: Autologous Chondrocyte Implantation Market, Europe, 2005 - 2015 (€) 6
• Chart 1-7: Leading Competitors, Orthopedic Biomaterial Market, Europe, 2008 8

RESEARCH METHODOLOGY 9

OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS 20

• Chart 3-1: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (€) 24
• Chart 3-2: Total European Orthopedic Biomaterial Market by Segment, Europe, 2008 26
• Chart 3-3: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2008 32

COUNTRY PROFILES 35

• Chart 4-1: German Price Index, GDP per Capita, and Population, 2008 36
• Chart 4-2: French Price Index, GDP per Capita, and Population, 2008 37
• Chart 4-3: U.K. Price Index, GDP per Capita, and Population, 2008 38
• Chart 4-4: Spanish Price Index, GDP per Capita, and Population, 2008 39
• Chart 4-5: Italian Price Index, GDP per Capita, and Population, 2008 40
• Chart 4-6: Beneluxian Price Index, GDP per Capita, and Population, 2008 41
• Chart 4-7: Scandinavian Price Index, GDP per Capita, and Population, 2008 42
• Chart 4-8: Swiss Price Index, GDP per Capita, and Population, 2008 43
• Chart 4-9: Austrian Price Index, GDP per Capita, and Population, 2008 44
• Chart 4-10: Portuguese Price Index, GDP per Capita, and Population, 2008 45
• Chart 4-11: Greek Price Index, GDP per Capita, and Population, 2008 46
• Chart 4-12: Bone Graft Substitute Procedures per Population, Europe, 2008 47

BONE GRAFT SUBSTITUTE MARKET 48

• Chart 5-1: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (€) 54
• Chart 5-2: Total Market Value by Country, Europe, 2008 (€) 56
• Chart 5-3: Total Bone Graft Substitute Procedures by Country, Europe, 2008 (€) 57
• Chart 5-4: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (€) 94
• Chart 5-5: Total Bone Graft Substitute Market, France, 2005 - 2015 (€) 126
• Chart 5-6: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (€) 158
• Chart 5-7: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (€) 190
• Chart 5-8: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (€) 222
• Chart 5-9: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (€) 254
• Chart 5-10: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€) 286
• Chart 5-11: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€) 319
• Chart 5-12: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (€) 351
• Chart 5-13: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (€) 383
• Chart 5-14: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (€) 415

BMP GROWTH FACTOR MARKET 445

• Chart 6-1: Orthopedic Growth Factor Market, Europe, 2005 - 2015 (€) 447
• Chart 6-2: Leading Competitors, Orthopedic Growth Factor Market, Europe, 2008 452

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 454

• Chart 7-1: Total Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015456
• Chart 7-2: Total Single-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015 458
• Chart 7-3: Total Three-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015 460
• Chart 7-4: Total Five-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015 462
• Chart 7-5 Hyaluronic Acid Viscosupplementation Injections per Country, Europe, 2008 464
• Chart 7-6: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2008 469

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 470

• Chart 8-1: ACI Market, Europe, 2005 - 2015 (€) 472

PLATELET AND BONE MARROW CONCENTRATION MARKET 478

• Chart 9-1: Figure 9-1: Total Cell Concentration Market, Europe, 2005 - 2015 (€)481
• Chart 9-2: Platelet Concentration Market, Europe, 2005 - 2015 (€) 483
• Chart 9-3: Bone Marrow Concentration Market, Europe, 2005 - 2015 (€) 485
• Chart 9-4: Leading Competitors, Platelet and Bone Marrow Concentration Market, Europe, 2008 490

ABBREVIATIONS 491

APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES 492